世界のグライコミクス市場予測2022年-2027年

【英語タイトル】Glycomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

IMARCが出版した調査資料(IMARC22OT0178)・商品コード:IMARC22OT0178
・発行会社(調査会社):IMARC
・発行日:2022年7月12日
・ページ数:143
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,499 ⇒換算¥369,852見積依頼/購入/質問フォーム
Five UserUSD3,499 ⇒換算¥517,852見積依頼/購入/質問フォーム
EnterprisewideUSD4,499 ⇒換算¥665,852見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
IMARC社の本市場調査資料では、2021年におよそ12.1億ドルであった世界のグライコミクス市場規模が2027年25.2億ドルに達し、2022年から2027年の間に年平均12.80%以上成長すると予測しています。本書では、グライコミクスの世界市場について調査し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別(酵素、インスツルメンツ、キット、試薬)分析、用途別(創薬・開発、診断薬、その他)分析、エンドユーザー別(学術・研究機関、製薬会社、バイオテクノロジー企業、受託研究機関(CRO))分析、地域別(北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを整理しております。本書では、Agilent Technologies Inc.、Asparia Glycomics、Bruker Corporation、Danaher Corporation、Dextra Laboratories Limited(New Zealand Pharmaceuticals Limited)、Merck KGaA、New England Biolabs、RayBiotech Life Inc.などの企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界のグライコミクス市場規模:製品別
- グライコミクス酵素の市場規模
- グライコミクスインスツルメンツの市場規模
- グライコミクスキットの市場規模
- グライコミクス試薬の市場規模

・世界のグライコミクス市場規模:用途別
- 創薬・開発用グライコミクスの市場規模
- 診断薬用グライコミクスの市場規模
- その他用途の市場規模

・世界のグライコミクス市場規模:エンドユーザー別
- 学術・研究機関における市場規模
- 製薬会社における市場規模
- バイオテクノロジー企業における市場規模
- 受託研究機関(CRO)における市場規模

・世界のグライコミクス市場規模:地域別
- 北米のグライコミクス市場規模
- アジア太平洋のグライコミクス市場規模
- ヨーロッパのグライコミクス市場規模
- 中南米のグライコミクス市場規模
- 中東/アフリカのグライコミクス市場規模

・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況
❖ レポートの概要 ❖

The global glycomics market reached a value of US$ 1.21 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.52 Billion by 2027, exhibiting a CAGR of 12.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Glycomics refers to a study that aids in defining or quantifying the glycome of a cell, tissue, or organism. It mainly assists in identifying the structure and function of the complete set of glycans produced in a single organism and determining all the genes that encode glycoproteins. It also aids in establishing the role of carbohydrate-protein interactions in cell-cell communication. As a result, glycomics finds extensive application in diagnostics, drug discovery, and immunology across the globe.

Glycomics Market Trends:
Presently, there is a rise in the prevalence of chronic diseases on account of sedentary lifestyles and the growing number of individuals who smoke and consume alcohol. In line with this, the coronavirus disease (COVID-19) outbreak has positively influenced the demand for vaccine and treatment drugs to prevent the spread of the pandemic worldwide. This, in turn, is strengthening the growth of the glycomics market. Besides this, glycomics is gaining preference for training and educational purposes around the world. This, in confluence with its extensive applicability in research centers due to the increasing adoption of glycan structure data analysis, is contributing to market growth. Furthermore, leading market players are continuously funding research and development (R&D) activities to enhance the ability of structurally complex glycans to be employed as therapeutics. Consequently, they are developing advanced technologies, such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and capillary electrophoresis (CE) in chemical and biochemical research. Moreover, a growing number of Contract Research Organizations (CROs) for the development and production of drugs and biologics is driving the market. Some of the other factors, such as the thriving pharmaceutical industry, rising number of clinical trials, and the improving healthcare infrastructure, are anticipated to propel the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global glycomics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Enzymes
Glycosidases
Glycosyltransferases
Neuraminidases
Sialyltransferases
Others
Instruments
Mass Spectrometers
HPLC
MALDI-TOF
Array systems
Others
Kits
Glycan Labeling Kits
Glycan Purification Kits
Glycan Release Kits
Others
Reagents
Glycoproteins
Monosaccharides
Oligosaccharides
Others

Breakup by Application:

Drug Discovery and Development
Diagnostics
Others

Breakup by End User:

Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Asparia Glycomics, Bruker Corporation, Danaher Corporation, Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited), Merck KGaA, New England Biolabs, RayBiotech Life Inc., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report:
How has the global glycomics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global glycomics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global glycomics market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Glycomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Enzymes
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Glycosidases
6.1.2.2 Glycosyltransferases
6.1.2.3 Neuraminidases
6.1.2.4 Sialyltransferases
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Mass Spectrometers
6.2.2.2 HPLC
6.2.2.3 MALDI-TOF
6.2.2.4 Array systems
6.2.2.5 Others
6.2.3 Market Forecast
6.3 Kits
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Glycan Labeling Kits
6.3.2.2 Glycan Purification Kits
6.3.2.3 Glycan Release Kits
6.3.2.4 Others
6.3.3 Market Forecast
6.4 Reagents
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Glycoproteins
6.4.2.2 Monosaccharides
6.4.2.3 Oligosaccharides
6.4.2.4 Others
6.4.3 Market Forecast
7 Market Breakup by Application
7.1 Drug Discovery and Development
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Academic and Research Institutes
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmaceutical and Biotechnology Companies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Contract Research Organizations (CROs)
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Asparia Glycomics
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bruker Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Danaher Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck KGaA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 New England Biolabs
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 RayBiotech Life Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Shimadzu Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Takara Bio Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Waters Corporation
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis



★調査レポート[世界のグライコミクス市場予測2022年-2027年] (コード:IMARC22OT0178)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のグライコミクス市場予測2022年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆